| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Sang-Woo Kim | |
| Dongwoo Khang | |||
| P2860 | cites work | Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology | Q26849264 |
| Human mesenchymal stem cells modulate allogeneic immune cell responses | Q28288692 | ||
| Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death | Q28363890 | ||
| Mesenchymal stem cells in health and disease | Q29614296 | ||
| Mesenchymal stem cells within tumour stroma promote breast cancer metastasis | Q29614303 | ||
| Targeting multidrug resistance in cancer | Q29616803 | ||
| Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production | Q29619807 | ||
| Bcl-2 functions in an antioxidant pathway to prevent apoptosis | Q29620401 | ||
| Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. | Q30489569 | ||
| Tissue- and organ-selective biodistribution of NIR fluorescent quantum dots | Q30491873 | ||
| Deep-tissue anatomical imaging of mice using carbon nanotube fluorophores in the second near-infrared window | Q30500816 | ||
| Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution | Q30524254 | ||
| Deaths: final data for 2009. | Q30833841 | ||
| Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles | Q33224381 | ||
| Efficient cytoplasmic protein delivery by means of a multifunctional envelope-type nano device | Q33281167 | ||
| Development of lipid particles targeted via sugar-lipid conjugates as novel nuclear gene delivery system | Q33305511 | ||
| A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway | Q33308413 | ||
| Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes | Q33344414 | ||
| Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice | Q33398443 | ||
| Endocytosis and exocytosis of nanoparticles in mammalian cells | Q33627669 | ||
| Multidrug Efflux Pumps and Cancer Stem Cells: Insights Into Multidrug Resistance and Therapeutic Development | Q58277244 | ||
| ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption | Q60775760 | ||
| Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection | Q62098835 | ||
| Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models | Q62100948 | ||
| Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents | Q64379193 | ||
| Long-circulating (sterically stabilized) liposomes for targeted drug delivery | Q72755730 | ||
| Possibility of active targeting to tumor tissues with liposomes | Q73850594 | ||
| Trends and developments in liposome drug delivery systems | Q73890337 | ||
| Factor(s) from nonmacrophage bone marrow stromal cells inhibit Lewis lung carcinoma and B16 melanoma growth in mice | Q77838827 | ||
| MITO-Porter: A liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion | Q80134787 | ||
| Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody | Q80351088 | ||
| Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes | Q80510046 | ||
| Enhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum(IV) prodrug of cisplatin | Q86555025 | ||
| Both human and mouse mesenchymal stem cells promote breast cancer metastasis. | Q39505707 | ||
| Selective targeting of gold nanorods at the mitochondria of cancer cells: implications for cancer therapy | Q39615451 | ||
| Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors. | Q39670726 | ||
| The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice. | Q39836181 | ||
| Organelle-targeted nanocarriers: specific delivery of liposomal ceramide to mitochondria enhances its cytotoxicity in vitro and in vivo | Q39963707 | ||
| Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells | Q40026176 | ||
| Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models | Q40062045 | ||
| Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. | Q40139914 | ||
| Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. | Q40195961 | ||
| Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells | Q40217732 | ||
| Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid | Q40242581 | ||
| Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway | Q40340698 | ||
| Epidermal growth factor receptor-transfected bone marrow stromal cells exhibit enhanced migratory response and therapeutic potential against murine brain tumors | Q40434909 | ||
| Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix | Q40617695 | ||
| Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery | Q40713744 | ||
| A vindesine-anti-CEA conjugate cytotoxic for human cancer cells in vitro | Q41490919 | ||
| Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticles | Q42803406 | ||
| Significant and prolonged antisense effect of a multifunctional envelope-type nano device encapsulating antisense oligodeoxynucleotide | Q42803620 | ||
| Intranuclear DNA release is a determinant of transfection activity for a non-viral vector: biocleavable polyrotaxane as a supramolecularly dissociative condenser for efficient intranuclear DNA release | Q42824876 | ||
| Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method | Q42827213 | ||
| Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour delivery. | Q43012179 | ||
| Mechanism of polyplex- and lipoplex-mediated delivery of nucleic acids: real-time visualization of transient membrane destabilization without endosomal lysis | Q44050228 | ||
| Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape | Q44591306 | ||
| A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo. | Q45954796 | ||
| Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo | Q46067245 | ||
| Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice | Q46535897 | ||
| Toxicity and tissue distribution of magnetic nanoparticles in mice. | Q46764075 | ||
| In vivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administration | Q46883760 | ||
| Size and shape effects in the biodistribution of intravascularly injected particles. | Q47588670 | ||
| Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats | Q48359484 | ||
| Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas | Q48926056 | ||
| Imaging the cell entry of the anthrax oedema and lethal toxins with fluorescent protein chimeras. | Q50554709 | ||
| Octaarginine-modified multifunctional envelope-type nano device for siRNA. | Q51012611 | ||
| PEG-modified gold nanorods with a stealth character for in vivo applications. | Q51154004 | ||
| Conditioned side effects induced by cancer chemotherapy: prevention through behavioral treatment. | Q52257887 | ||
| Surface chemistry of gold nanoparticles mediates their exocytosis in macrophages. | Q53280836 | ||
| Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. | Q53421447 | ||
| Richard Feynman | Q55453696 | ||
| Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype | Q56902900 | ||
| Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors | Q33649082 | ||
| Design considerations of iron-based nanoclusters for noninvasive tracking of mesenchymal stem cell homing | Q33716075 | ||
| Targeting of drugs and nanoparticles to tumors | Q33751710 | ||
| Drug delivery to mitochondria: the key to mitochondrial medicine | Q33853014 | ||
| Endocytosis of nanomedicines. | Q33987301 | ||
| Strategies for advancing cancer nanomedicine | Q33995719 | ||
| Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells. | Q34028841 | ||
| Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects | Q34030709 | ||
| Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles | Q34079604 | ||
| Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis | Q34093260 | ||
| The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. | Q34101262 | ||
| PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics | Q34149180 | ||
| Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging | Q34162598 | ||
| Molecular mechanisms of drug resistance | Q34382998 | ||
| Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. | Q34559072 | ||
| Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration | Q34634591 | ||
| A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors. | Q34708838 | ||
| Targeting HER2+ breast cancer cells: lysosomal accumulation of anti-HER2 antibodies is influenced by antibody binding site and conjugation to polymeric nanoparticles. | Q34861044 | ||
| The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agents | Q34864544 | ||
| Biodegradable nanoparticles for drug and gene delivery to cells and tissue | Q35082117 | ||
| Octaarginine-modified multifunctional envelope-type nanoparticles for gene delivery | Q35741659 | ||
| Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo | Q35947255 | ||
| Preclinical predictors of anticancer drug efficacy: critical assessment with emphasis on whether nanomolar potency should be required of candidate agents | Q35996689 | ||
| Antibody targeted drugs as cancer therapeutics | Q36373103 | ||
| Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery | Q36409586 | ||
| Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy | Q36446288 | ||
| Polymer conjugates as anticancer nanomedicines | Q36561667 | ||
| Particle shape enhances specificity of antibody-displaying nanoparticles | Q36653978 | ||
| Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging | Q36765663 | ||
| The role of complement in inflammation and phagocytosis | Q36845189 | ||
| Endocytic mechanisms for targeted drug delivery | Q36894849 | ||
| Alternate routes for drug delivery to the cell interior: pathways to the Golgi apparatus and endoplasmic reticulum | Q36899294 | ||
| Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution | Q37036373 | ||
| Effect of injection routes on the biodistribution, clearance, and tumor uptake of carbon dots | Q37051240 | ||
| Mesenchymal stem cells: an emerging tool for cancer targeting and therapy | Q37066661 | ||
| Pharmacokinetics and biodistribution of nanoparticles | Q37210459 | ||
| Bcl-2 family proteins and cancer | Q37310180 | ||
| Brain cancer stem cells display preferential sensitivity to Akt inhibition | Q37335643 | ||
| Shape effects of filaments versus spherical particles in flow and drug delivery | Q37338776 | ||
| Mesenchymal stem cell homing: the devil is in the details | Q37407769 | ||
| Facing the truth about nanotechnology in drug delivery | Q37555555 | ||
| Effect of surface properties on nanoparticle-cell interactions | Q37618632 | ||
| Subcellular targeting strategies for drug design and delivery | Q37665298 | ||
| Protein toxins from plants and bacteria: probes for intracellular transport and tools in medicine | Q37729388 | ||
| Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy | Q37759347 | ||
| Nanomedicinal strategies to treat multidrug-resistant tumors: current progress | Q37763152 | ||
| A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma. | Q37788834 | ||
| Inorganic Nanoparticles in Cancer Therapy | Q37812005 | ||
| Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance. | Q37844303 | ||
| Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials | Q37869062 | ||
| Mesenchymal stem cells: a potential targeted-delivery vehicle for anti-cancer drug, loaded nanoparticles | Q38024632 | ||
| Liposomal drug delivery systems: from concept to clinical applications | Q38049376 | ||
| Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles | Q38078983 | ||
| Carbon nanotubes in cancer therapy: a more precise look at the role of carbon nanotube-polymer interactions | Q38084838 | ||
| Stimuli-responsive nanocarriers for drug delivery. | Q38154805 | ||
| Nanopreparations for organelle-specific delivery in cancer | Q38165639 | ||
| Immunotherapy applications of carbon nanotubes: from design to safe applications. | Q38196056 | ||
| Stem cell-based therapies for cancer treatment: separating hope from hype | Q38245163 | ||
| RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo | Q38302673 | ||
| Gastrointestinal uptake of biodegradable microparticles: effect of particle size | Q38559899 | ||
| Biodegradable long-circulating polymeric nanospheres | Q38569096 | ||
| Nano-engineered mesenchymal stem cells as targeted therapeutic carriers | Q38933982 | ||
| Nullifying tumor efflux by prolonged endolysosome vesicles: development of low dose anticancer-carbon nanotube drug | Q39096775 | ||
| Silica nanorattle-doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy. | Q39176028 | ||
| Octa-arginine-modified pegylated liposomal doxorubicin: an effective treatment strategy for non-small cell lung cancer. | Q39192389 | ||
| PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation | Q39226939 | ||
| Intracellular trafficking mechanism, from intracellular uptake to extracellular efflux, for phospholipid/cholesterol liposomes | Q39303440 | ||
| Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy | Q39441727 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial | Q6936496 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell | Q7868 |
| mesenchymal stem cell | Q1922379 | ||
| antineoplastic | Q2853144 | ||
| manufactured product | Q3406743 | ||
| nanocarrier | Q17153796 | ||
| drug delivery system | Q64829245 | ||
| P304 | page(s) | 3989-4008 | |
| P577 | publication date | 2015-01-01 | |
| 2015-06-17 | |||
| P1433 | published in | International Journal of Nanomedicine | Q6051502 |
| P1476 | title | Multiple cues on the physiochemical, mesenchymal, and intracellular trafficking interactions with nanocarriers to maximize tumor target efficiency | |
| P478 | volume | 10 |
Search more.